The World’s First Child With Down Syndrome Medical Training Manikin Debuts Jan. 23 at the International Meeting on Simulation in Healthcare in Orlando, Florida

The World’s First Child With Down Syndrome Medical Training Manikin Debuts Jan. 23 at the International Meeting on Simulation in Healthcare in Orlando, FloridaGwen, her family and the creators of this monumental training manikin will be available for media interviews Jan. 23, 2023, 9:30am-11:30am at the Orange County Convention Center. Press passes must be secured by Jan. 17 for the Jan. 23, 2023, event.

The World’s First Child With Down Syndrome Medical Training Manikin Debuts Jan. 23 at the International Meeting on Simulation in Healthcare in Orlando, Florida
Gwen

Gwen seeing the Gwen manikin for the first time.

ORLANDO, Fla. – January 9, 2023 – (Newswire.com)

Lifecast Body Simulation Global (Echo Healthcare), a leader in hyper-realistic training manikins, will debut the world’s first Child with Down Syndrome training manikin Jan. 23 at the International Meeting on Simulation in Healthcare (IMSH) conference in Orlando, Florida. This realistic medical manikin was formed from a real-life 3D body scan of a seven-year-old girl with Down syndrome named Gwen and will be available to healthcare education facilities around the world to facilitate specialty and inclusive training in managing patients with Down syndrome.

Gwen was created by Lifecast Body Simulation and the University of Greenwich, which received support from the Down Syndrome Association. This debut is monumental in the world of medical education and is guaranteed to make waves at the largest international medical simulation conference held in the U.S. There is no other medical training manikin available that accurately represents a child with Down syndrome, making Gwen the first in the world. The Gwen manikin allows healthcare providers to become accurately trained on how to treat a patient with Down Syndrome. Given variations in their airway, stature and anatomy, without proper training, additional harm can be unintentionally done by medical providers.

Down syndrome is a genetic disorder caused when abnormal cell division results in extra genetic material from chromosome 21. While varied amongst patients, a few common physical traits of Down syndrome are low muscle tone, a difficult airway for intubation, smaller stature, toe gapping, almond-shaped eyes, a single deep crease across the center of the palm, smaller hands and feet – all of which are accurately represented in the Gwen manikin.

“We are thrilled to offer the world’s first medical manikin focusing on Down syndrome. Children with Down Syndrome are truly amazing but also very complex to treat from a medical standpoint. Our goal with the Gwen manikin is to ensure every healthcare provider is properly trained for when they do encounter a child with Down Syndrome in their clinical practice so we can mitigate any risk and ultimately improve patient safety,” says Kevin King, CEO of Lifecast Body Simulation Global.

The Gwen manikin, along with the real-life Gwen and her family, will be at the International Meeting on Simulation in Healthcare (IMSH) to meet with the local media on Jan. 23, 2023, from 9:30am – 11:30am in Echo Healthcare Booth #111. Press passes are required to enter the conference exhibit area to interview Gwen and her family, the creators of the Gwen manikin and healthcare providers. Please contact Nicole Sherk prior to Jan. 17 to secure your press pass.

Contact Information:

Nicole Sherk

Marketing Manager
[email protected]

9412330854

Press Release Service
by
Newswire.com

Original Source:

The World’s First Child With Down Syndrome Medical Training Manikin Debuts Jan. 23 at the International Meeting on Simulation in Healthcare in Orlando, Florida

Continue Reading

Ukraine works to restore electricity as Zelensky warns of further Russian missile strikes – BBC News

Ukraine works to restore electricity as Zelensky warns of further Russian missile strikes – BBC NewsWork is continuing in Ukraine to restore electricity in homes, hospitals and critical infrastructure following the ninth wave of Russian missile strikes on Friday. The attacks have targeted civilian infrastructure, as temperatures drop below freezing in many regions. Kyiv has accused Moscow of using winter as a weapon. President Volodymyr Zelensky has said Russia has […]

Continue Reading

Nile Launches Smart Titration™ for Epilepsy Digital Care Platform

Nile Launches Smart Titration™ for Epilepsy Digital Care PlatformNile’s Smart Titration™ provides simplified access to support physicians when building complex titrations for epilepsy medication

Nile Launches Smart Titration™ for Epilepsy Digital Care Platform
Nile Smart Titration

Nile Smart Titration ASD Tool

SHERMAN OAKS, Calif. – January 6, 2023 – (Newswire.com)

Nile AI, Inc. announced today that it has launched its Nile® Smart TitrationTM feature, designed to simplify for clinicians and patients the medication changes frequently utilized for people living with epilepsy. A unique offering among epilepsy patient apps, Smart TitrationTM provides simplified access to medication titration data and allows clinicians to quickly set medication titration schedules for commonly utilized anti-seizure medications (ASMs). Once set and reviewed, the clinician easily sends the updated schedule of medication changes directly to the individual’s Nile epilepsy management app. 

Nile’s digital platform consists of a patient app and a clinician portal. The patient app is an intuitive, smart tool for patients to feel connected with their care team, learn about their journey, and understand and track their progress. The clinician portal offers the ability to view the status of patients at a glance, virtually informs and supports their patients in between appointments, and allows for more data-driven, efficient changes, if needed.

“We know that individuals living with epilepsy sometimes struggle with the many medication changes that may be required to gain better seizure control,” said John Hixson, M.D., Chief Medical Officer of Nile AI, Inc. “We are working to provide better tools to facilitate optimal care and communication between clinicians and patients, and we hope that the Smart TitrationTM tool is another valuable part of a comprehensive care management platform for epilepsy.”

About Nile  

Nile AI, Inc., was created to improve care for people living with epilepsy, their caregivers, and healthcare providers (HCPs). Nile was founded with a clear mission in mind: to make the journey of every epilepsy patient more predictable. To that end, Nile offers an epilepsy care management platform that serves as a management tool for the healthcare provider (HCP) and provides patients with peace of mind between consultations, with the ultimate goal of shortening the path to optimal treatment.

Nile, Replacing Trying with Knowing®. For more information, visit www.Nile.ai.

Contact Information:

Nile AI, Inc.
[email protected]

Press Release Service
by
Newswire.com

Original Source:

Nile Launches Smart Titration™ for Epilepsy Digital Care Platform

Continue Reading

AQuity and Savista Announce Strategic Partnership for Savista Transcription & Clinical Documentation Clients

AQuity and Savista Announce Strategic Partnership for Savista Transcription & Clinical Documentation ClientsCurrent Savista clients will migrate to AQuity’s industry-leading solutions in 2023 in a planned migration

ALPHARETTA, Ga. – January 5, 2023 – (Newswire.com)

AQuity Solutions and Savista today announced a strategic partnership and jointly-planned migration of current Savista transcription clients in 2023 to AQuity’s market-leading clinical documentation capture solutions. AQuity has been consistently recognized by KLAS and Black Book as the benchmark in the clinical documentation solutions sector, with over 45 years of experience in healthcare. Traditional transcription remains a critical part of middle-revenue cycle. The accurate capture of the clinical encounter, patient treatment, and severity of illness is key for proper care and appropriate reimbursement. 

“We are delighted to welcome legacy Savista transcription and clinical documentation clients to AQuity through this strategic partnership with Savista,” added Kashyap Joshi, CEO of AQuity. “Traditional transcription workflows continue to be a vital part of healthcare revenue cycle and we continue to see transcription as an important option for our healthcare providers to properly capture the patient story and deliver care to patients.”

“The AQuity transcription platform adds significant value to our Transcription service clients,” added Laxmi Patel, Chief Strategy Officer of Savista. “The platform’s unique security and reporting features, complemented by the strength of their ongoing product development, are true competitive advantages in this still important segment of our industry. This technology partnership supports our commitment to serve our clients with the best tools available.”

About Savista

Savista is a prominent provider of healthcare revenue cycle management services, partnering with hospitals, systems, physician practices and ambulatory surgery centers for over 30 years. They solve revenue cycle challenges through their comprehensive audits and assessments and expert staffing solutions that span eligibility and enrollment, CDM, coding, AR and more. Their global organization delivers custom solutions to over 300 clients across 770 facilities in 49 states. To learn more about Savista, please visit SavistaRCM.com.

About AQuity

Headquartered in Cary, NC, AQuity employs over 7,500 clinical documentation and medical coding professionals across the United States, India, Australia, Canada, and the U.K. With over 45 years of experience in service and technology solutions, AQuity is recognized year after year by KLAS and Black Book as a leading vendor in multiple disciplines with over 20 recognitions. AQuity is privately held.

https://aquitysolutions.com/

PRESS CONTACTS

Kim Wiethorn                                                

VP, Marketing and Communications              

[email protected]                      

513-884-7597                                                     

Contact Information:

Dale Kivi

Senior Director of Communications
[email protected]

804.339.9017

Press Release Service
by
Newswire.com

Original Source:

AQuity and Savista Announce Strategic Partnership for Savista Transcription & Clinical Documentation Clients

Continue Reading

ZetrOZ Systems Hosts Lunch and Lecture for the Professional Baseball Athletic Trainers Society

ZetrOZ Systems Hosts Lunch and Lecture for the Professional Baseball Athletic Trainers SocietyThe lunch and lecture provided scientific updates on sustained acoustic medicine research in sports medicine, significant product innovations, and the new 2023 Player Performance Package (PPP).

ZetrOZ Systems Hosts Lunch and Lecture for the Professional Baseball Athletic Trainers Society
ZetrOZ presents at the MLB winter meetings to PBATS

ZetrOZ presents at the MLB winter meetings to PBATS

SAN DIEGO – January 5, 2023 – (Newswire.com)

ZetrOZ Systems hosted a Lunch and Lecture for The Professional Baseball Athletic Trainers Society (PBATS) during the Major League Baseball Winter Meetings at the Manchester Grand Hyatt in San Diego, California. Founder and CEO Dr. George Lewis presented scientific updates on sustained acoustic medicine (sam®) research in sports medicine, reviewed a 2022 Healthcare Provider Survey on utilization within professional athletics and results from real-world clinicals, and introduced its Player Performance Packages for 2023.

“It was a pleasure to have the opportunity to speak with The Professional Baseball Athletic Trainers Society,” said Dr. Lewis. “I am grateful for the opportunity to share my knowledge and recent findings with such a professional and dedicated group of trainers. I look forward to continuing the conversation and working together to improve the health, performance and recovery of athletes in the future.”

Some of the key findings from the latest sports medicine research include the following:

  • Professional sports medical staff had an 87% satisfaction rate pDraper et al. 2021 J. Ortho. Practice).
  • When patients failed to respond to physical therapy, sam® proved to be a helpful adjunct to facilitate healing and return to work (Winkler et al. 2021 Nature Sports Med).
  • Athletic Trainers working within the professional, collegiate and military levels found sam® provided clinical patient improvement in under two weeks of treatment and a 50% reduction of pain medication pWalters et al. 2022 Open Orthopedics).
  • 87.3% of athletes are highly receptive to treatment, have a high confidence level for improved function, and return to work after 30 days of sam® use pOpen Orthopedics).

Over 30 studies back sustained acoustic medicine’s effectiveness, and over 1 million individuals have used sam® to treat soft tissue injuries. Today, 99% of Major League Baseball (MLB) organizations utilize sam® to treat injuries and accelerate soft tissue healing.

Dr. Lewis also introduced the company’s 2023 Player Performance Packages, designed for prophylactic injury prevention and soft tissue healing. A package includes one sam®x1 unit, a 10-week supply of patches, and 100% damage coverage. ZetrOZ is preparing its deployment training over the next several weeks before MLB’s 2023 Spring Training, officially beginning on Friday, Feb. 24.

“Now every player from the big leagues to the minors has access to sam® treatment. We are looking to reduce common injuries to the shoulder and elbow,” he added.

sam® is the first and only FDA-cleared, non-surgical and drug-free wearable long-duration mechanobiological device for home use designed to treat chronic inflammatory diseases and accelerate soft tissue healing. To learn more, visit zetroz.com.

About ZetrOZ Systems

ZetrOZ Systems is leading healing innovations in sports medicine and developing wearable bioelectronic devices for the delivery of sustained acoustic medicine (sam®). Researched and funded by the federal government, ZetrOZ is built on proprietary medical technology of +46 patents and is the exclusive manufacturer and developer of sam®, a product line designed for the treatment of acute and chronic musculoskeletal conditions. To learn more, visit zetrozsystems.com.

Contact Information:

Buse Kayar
[email protected]

Press Release Service
by
Newswire.com

Original Source:

ZetrOZ Systems Hosts Lunch and Lecture for the Professional Baseball Athletic Trainers Society

Continue Reading